Neurology trials require more than speed — they require certainty.
Our integrated teams bring precision, regulatory insight, and therapeutic depth to every neurological trial.
WHY BIORASI FOR NEUROLOGY
When it comes to CNS and neurology trials, Biorasi delivers: Trusted investigator networks, regulatory foresight, and operational discipline. From Alzheimer’s and Parkinson’s to cell therapy and epilepsy, we work side-by-side with sponsors to navigate complexity and bring structure to every phase.
Subspecialties
- Parkinson’s Disease
- Epilepsy
- Multiple Sclerosis
- ALS
Proof of
Performance
- 52 Studies
- 27 Indications
- 3,389 Patients Enrolled
Case Studies and Results
- Rescue of Phase III Parkinson’s Disease Trial
- Enrolled 33 patients in 9.5 months
- 3x enrollment vs incumbent
- Met original deadline and budget
- Delivered on trial completion and data lock
FROM OUR PARTNERS
“In addition to hitting their recruitment target, Biorasi brought fresh energy to our trial. Their involvement helped motivate our incumbent CRO to raise their performance and accelerated execution across the entire study team.”
From the Library
Article
“DIABESITOLOGY”: A Call to Action for Novel Clinical Trial Designs in the Golden Era of GLP-1 Axis Medications
Article
Biorasi Welcomes Neurology Professor Dr. Ole Isacson to Scientific Advisory Board
Article
Biorasi Meets First Patient, First Visit Milestone for Dermatology Trial During COVID-19
Article